Average Co-Inventor Count = 9.18
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (51 from 378 patents)
2. Bayer Intellectual Property Gmbh (26 from 721 patents)
3. Bayer Aktiengesellschaft (10 from 12,167 patents)
4. The Broad Institute, Inc. (9 from 445 patents)
5. Dana-Farber-Cancer Institute Inc. (6 from 1,211 patents)
6. Bayer Schering Pharma Ag (1 from 192 patents)
7. Bayer Pharma Aktiengesellscaft (1 from 1 patent)
78 patents:
1. 12427153 - 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases
2. 12258323 - Dihydrooxadiazinones
3. 12053476 - Compounds, compositions and methods for cancer patient stratification and cancer treatment
4. 11773070 - Dihydrooxadiazinones
5. 11691986 - PTEFB inhibiting macrocyclic compounds
6. 11529356 - 2-(morpholin-4-yl)-1,7-naphthyridines
7. 11492358 - Macrocyclic indole derivatives
8. 11427553 - Dihydrooxadiazinones
9. 11254690 - PTEFb inhibiting macrocyclic compounds
10. 11242356 - PTEFb inhibiting macrocyclic compounds
11. 11142522 - Compounds, compositions and methods for cancer treatment
12. 10981932 - Macrocyclic indole derivatives
13. 10966986 - Compounds, compositions and methods for cancer patient stratification and cancer treatment
14. 10894784 - Heteroarylbenzimidazole compounds
15. 10772893 - 2-(morpholin-4-yl)-1,7-naphthyridines